Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma

Clinical trial NCT07123545 · RECRUITING

Trial details

NCT number: NCT07123545
Sponsor: Zhejiang University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma (HCC)

Start date: 2025-08-01
Primary completion: 2027-07-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.